News by subject: IPO

Ajax I (the "Company") today announced that, commencing December 18, 2020, holders of the units sold in the Company's initial public offering of 80,499,090 units completed on October 30, 2020, may elect to separately trade the Class A ordinary...

UiPath, Inc. today announced that it has submitted a draft registration statement on a confidential basis to the U.S. Securities and Exchange Commission (the "SEC") for a proposed public offering of its Class A common stock. The number of shares of...

Virios Therapeutics, Inc. (the "Company"), a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, today announced the pricing of its initial public offering...

The New York Stock Exchange , a wholly-owned subsidiary of Intercontinental Exchange , a leading operator of global exchanges and clearing houses and provider of mortgage technology, data and listings services, ranked once again as the leader in...

Pegasus Development, Inc. is pleased to announce that the first important step for the planned IPO / Listing in 2021 has been taken. The application with the SEC / EDGAR - Securities and Exchange Commission in the USA has been approved and the...

Corner Growth Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more...

Certara, Inc. ("Certara"), a global leader in biosimulation by 2019 revenue, today announced that on December 15, 2020, it closed its upsized initial public offering of 33,413,250 shares of common stock at $23.00 per share. The closing includes...

Skillz Inc. ("Skillz"), the leading mobile games platform connecting players in fair, fun, and meaningful competition, today became the first publicly-traded mobile esports platform, following the completion of its combination with special purpose...

Self Esteem Brands (SEB), the parent company of Anytime Fitness, LLC, Basecamp Fitness, LLC, The Bar Method, LLC and Waxing the City Worldwide, LLC, today congratulated Fast Fitness Japan (FFJ) on its successful debut on the Tokyo Stock Exchange,...

Upstart Holdings, Inc. ("Upstart") announced today the pricing of its initial public offering of its common stock at a price to the public of $20.00 per share. Upstart is offering 9,000,000 shares of its common stock and selling stockholders are...

AbCellera Biologics Inc. ("AbCellera") , a technology company that aims to become the centralized operating system for next-generation antibody discovery, today announced the closing of its initial public offering of 27,772,500 common shares at a...

ContextLogic Inc. (d/b/a "Wish") today announced the pricing of its initial public offering of 46,000,000 shares of its Class A common stock at a price to the public of $24.00 per share. The shares are expected to begin trading on the Nasdaq Global...

Gores Holdings VI, Inc. (the "Company"), a blank check company sponsored by an affiliate of The Gores Group, LLC, a global investment firm founded in 1987 by Alec Gores, and formed for the purpose of entering into a merger, capital stock exchange,...

Motive Capital Corp (the "Company") today announced the closing of its initial public offering of 41,400,000 units, including 5,400,000 units pursuant to the full exercise of the underwriters' over-allotment option, at a public offering price of...

Taysha Gene Therapies, Inc. , a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations,...

Blade Urban Air Mobility, Inc. ("Blade" or the "Company"), a technology-powered air mobility company, announced today that it will become publicly listed in order to bolster Blade's growth trajectory within the rapidly growing urban air mobility...

Apartment Investment and Management Company ("Aimco") announced today that it has completed the separation of its businesses (the "Separation"), creating two, separate and distinct, publicly traded companies, Apartment Income REIT Corp. ("AIR") and...

Apartment Income REIT Corp. ("AIR") announced today that it has completed its separation from Apartment Investment and Management Company ("Aimco") (the "Separation"), becoming an independent, publicly-traded, self-managed and self-administered real...

Rocket Pharmaceuticals, Inc. ("Rocket"), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the closing of its previously announced upsized underwritten public...

RMG Acquisition Corp. II (the "Company") announced today the closing of its initial public offering of 34,500,000 units, which included the full exercise of the underwriters' over-allotment option, at a price of $10.00 per unit, resulting in gross...

908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced plans to commence the roadshow for an initial public offering of shares of its common stock, with 6,250,000...

WeCommerce Holdings Ltd. (the "Company") announces that its shares will begin trading on the TSX Venture Exchange on December 14, 2020 under the symbol WE. "This is an exciting moment for the WeCommerce team and our portfolio of companies," said...

CBRE Acquisition Holdings, Inc. today announced that Morgan Stanley has exercised in full its over-allotment option to purchase an additional 5,250,000 SAIL (Stakeholder Aligned Initial Listing) securities at the initial public offering price of...

Lux Health Tech Acquisition Corp. (the "Company") announced that, commencing December 14, 2020, holders of the units sold in the Company's initial public offering (the "Units") may elect to separately trade the shares of Class A common stock and...

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO ? ISIN : FR0011341205 ? the ??Company''), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the pricing of its initial public offering...

AbCellera Biologics Inc. ("AbCellera"), a technology company that aims to become the centralized operating system for next-generation antibody discovery, today announced the pricing of its initial public offering of 24,150,000 common shares at a...

Motive Capital Corp (the "Company") today announced the pricing of its initial public offering of 36,000,000 units at a price of $10.00 per unit. The Company has granted the underwriters of the offering a 45-day option to purchase up to an additional...

Roth CH Acquisition II Co. (the "Company") announced today the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market ("Nasdaq") and trade under the ticker...

Certara, Inc. ("Certara"), a global leader in biosimulation, today announced the pricing of its upsized initial public offering of 29,055,000 shares of its common stock at $23.00 per share. Certara is offering 14,630,000 shares of its common stock...

Gores Holdings VI, Inc. (the "Company"), a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses,...

CBRE Acquisition Holdings, Inc. today announced the pricing of its initial public offering of 35,000,000 SAIL (Stakeholder Aligned Initial Listing) securities at a price of $10.00 per SAIL security. The SAIL securities will be listed on the New York...

RMG Acquisition Corporation II (the "Company") announced today that it priced its initial public offering of 30,000,000 units, upsized from 25,000,000 units, at $10.00 per unit. The units will be listed on The Nasdaq Capital Market ("Nasdaq") and...

Acies Acquisition Corp. announced today that, commencing December 11, 2020, holders of the 21,525,000 units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in...

Rocket Pharmaceuticals, Inc. ("Rocket"), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the pricing of an upsized underwritten public offering of 4,642,858...

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO ? ISIN : FR0011341205 ? the ??Company''), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the filing of an amended registration on...

Periphas Capital Partnering Corporation (the "Company"), a company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with one or more businesses,...

Cyclo Therapeutics, Inc. ("Cyclo Therapeutics" or the "Company") , a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of Neurodegenerative Diseases, including their lead candidate (Trappsol® Cyclotm) in the...

Frazier Healthcare Partners' special purpose acquisition corporation, Frazier Lifesciences Acquisition Corporation, announced the pricing of its initial public offering of 12,000,000 units, at a price to the public of $10.00 per unit, for aggregate...

C3.ai, a leading enterprise AI software provider for accelerating digital transformation, announced today the pricing of its initial public offering of 15,500,000 shares of its Class A common stock at a price of $42.00 per share. C3.ai has granted...

Atara Biotherapeutics, Inc. , a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T- cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune...

Silverback Therapeutics, Inc. ("Silverback"), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic...

CBRE Acquisition Holdings, Inc. today announced the launch of its initial public offering of 35,000,000 SAIL (Stakeholder Aligned Initial Listing) securities. The company has applied to have its SAIL securities approved for listing on the New York...

Periphas Capital Partnering Corporation (the "Company"), a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with...

Rodgers Silicon Valley Acquisition Corp. announced today that it closed its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriter of their over-allotment option. The offering...

Revolution Acceleration Acquisition Corp (the "Company") announced today that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market ("Nasdaq") and trade under the ticker...

Docebo Inc. ("Docebo" or the "Company") today announced the closing of its previously-announced marketed public offering of common shares in the United States and Canada. A total of 3,450,000 common shares of Docebo were sold, including 450,000...

ContextLogic Inc. (d/b/a "Wish") today announced that it has launched the roadshow for the initial public offering of its Class A common stock. Wish is offering 46,000,000 shares of its Class A common stock. The initial public offering price is...

NANOBIOTIX (Paris:NANO) (Euronext: NANO ? ISIN : FR0011341205 ? the "Company"), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the start of its roadshow in connection with its intention to...

Trepont Acquisition Corp I (the "Company") announced the closing today of its initial public offering of 23,000,000 units at a price of $10.00 per unit, including an additional 3,000,000 units sold pursuant to the full exercise of the underwriters'...

Silverback Therapeutics, Inc. ("Silverback"), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic...